ATHERSYS, INC.

Address

3201 CARNEGIE AVE
CLEVELAND, OH, 44115-2634

Information

DUNS: 839321403
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Cell Therapy for the Treatment of Acute Respiratory Distress Syndrome

    Amount: $450,040.00

    DESCRIPTION provided by applicant This is a resubmission of a Phase I Phase II Fast Track application for the clinical use of MultiStem in patients with acute respiratory distress syndrome ARDS ...

    STTRPhase II2016Department of Health and Human Services
  2. Combinatorial Treatment of Acute Spinal Cord Injury with MultiStem Cell Therapy and Intracellular Sigma Peptide

    Amount: $212,796.00

    DESCRIPTION provided by applicant One out of every fifty people living in the United States suffers from some form of paralysis a total of almost million Americans This proposal outlines the tr ...

    SBIRPhase I2015Department of Health and Human Services
  3. Phase II Trial Evaluating the Safety and Efficacy of an Allogeneic Stem Cell for

    Amount: $1,708,006.00

    DESCRIPTION provided by applicant Cardiovascular disease CVD represents a significant unmet medical need with over million patients in the United States suffering from acute myocardial infarcti ...

    SBIRPhase II2015Department of Health and Human Services
  4. Cell Therapy for the Treatment of Acute Respiratory Distress Syndrome

    Amount: $224,721.00

    DESCRIPTION (provided by applicant): This is a resubmission of a Phase I-Phase II Fast-Track application for the clinical use of MultiStem in patients with acute respiratory distress syndrome (ARDS). ...

    STTRPhase I2014Department of Health and Human Services
  5. Pediatrician Office Drug Prevention

    Amount: $330,000.00

    DESCRIPTION (provided by applicant): Cardiovascular disease (CVD) represents a significant unmet medical need with over 1 million patients in the United States suffering from acute myocardial infarcti ...

    SBIRPhase I2013Department of Health and Human Services
  6. Cell Based Therapy for Treatment of Traumatic Brain Injury

    Amount: $1,555,219.00

    DESCRIPTION (provided by applicant): Previously performed and published studies have demonstrated that MultiStem(R), Athersys' patented adult adherent stem cell product, modulates the inflammato ...

    SBIRPhase II2013Department of Health and Human Services
  7. Cell Based Therapy for Treatment of Traumatic Brain Injury

    Amount: $299,999.00

    DESCRIPTION (provided by applicant): Previously performed and published studies have demonstrated that MultiStem(R), Athersys' patented adult adherent stem cell product, modulates the inflammato ...

    SBIRPhase I2012Department of Health and Human Services
  8. Optimization of the angiogenic potential of multipotent adult progenitor cells

    Amount: $99,302.00

    DESCRIPTION (provided by applicant): Peripheral Vascular Disease (PVD) results from chronic loss of the oxygen supply to the lower limbs due to arterial blockage. Loss of oxygen to these tissues can r ...

    SBIRPhase I2010Department of Health and Human Services
  9. Stem Cells for Neonatal Hypoxic-Ischemic Brain Injury

    Amount: $205,471.00

    DESCRIPTION: The specific objective of this STTR Phase II research and development project is to provide an optimized cellular therapy regimen for treating hypoxic-ischemic (HI) injury and its related ...

    STTRPhase II2007Department of Health and Human Services
  10. Stem Cells for Neonatal Hypoxic-Ischemic Brain Injury

    Amount: $136,500.00

    DESCRIPTION (provided by applicant): The emergence of technologies enabling isolation of adult stem cells has allowed evaluation of cell therapeutics for central nervous system disorders with a path ...

    STTRPhase I2006Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government